Cargando…

Efficacy of Phenotype-vs. Genotype-Guided Therapy Based on Clarithromycin Resistance for Helicobacter pylori Infection in Children

BACKGROUND: Clarithromycin resistance reduces the eradication rate of Helicobacter pylori (H. pylori). Cultures with susceptibility testing and molecular determination of genotypes are recommended to guide-tailored therapy. METHODS: We retrospectively enrolled patients aged 6 and 18 years with H. py...

Descripción completa

Detalles Bibliográficos
Autores principales:	Feng, Yan, Hu, Wenhui, Wang, Yuhuan, Lu, Junping, Zhang, Ye, Tang, Zifei, Miao, Shijian, Zhou, Ying, Huang, Ying
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Pediatrics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9002118/ https://www.ncbi.nlm.nih.gov/pubmed/35425727 http://dx.doi.org/10.3389/fped.2022.854519

Ejemplares similares

Genotypic and Phenotypic Resistance to Clarithromycin in Helicobacter pylori Strains
por: Gong, Eun Jeong, et al.
Publicado: (2020)

The Association Between Genetic Variants, Pharmacokinetics, and Infliximab Efficacy in Pediatric Patients With Crohn's Disease in China
por: Hu, Wenhui, et al.
Publicado: (2021)

Trends in Helicobacter pylori resistance to clarithromycin: from phenotypic to genomic approaches
por: Marques, Andreia T., et al.
Publicado: (2020)

Phenotype and Molecular Detection of Clarithromycin and Levofloxacin Resistance in Helicobacter pylori Clinical Isolates in Beijing
por: Lok, Chong-Hou, et al.
Publicado: (2020)

Comparison of levofloxacin versus clarithromycin efficacy in the eradication of Helicobacter pylori infection
por: Haji-Aghamohammadi, Ali Akbar, et al.
Publicado: (2016)

Early genetic diagnosis of clarithromycin resistance in Helicobacter pylori
por: Li, Xiao-Hua, et al.
Publicado: (2021)

Molecular Characterization of Clarithromycin Resistance in Helicobacter pylori Strains
por: Örsten, Serra, et al.
Publicado: (2023)

Complete Genome Sequences of Helicobacter pylori Clarithromycin-Resistant Strains
por: Binh, Tran Thanh, et al.
Publicado: (2013)

A Novel Reduction Strategy of Clarithromycin Resistance in Helicobacter pylori
por: Tadjrobehkar, Omid, et al.
Publicado: (2014)

Mutant selection window of clarithromycin for clinical isolates of Helicobacter pylori
por: Feng, Zi-Han, et al.
Publicado: (2019)

Is Only Clarithromycin Susceptibility Important for the Successful Eradication of Helicobacter pylori?
por: Kim, Young Min, et al.
Publicado: (2020)

Levofloxacin based vs clarithromycin based sequential therapy in helicobacter pylori eradication; a randomized clinical trial
por: Moradniani, Mosayeb, et al.
Publicado: (2018)

Genotypic determination of resistance and heteroresistance to clarithromycin in Helicobacter pylori isolates from antrum and corpus of Colombian symptomatic patients
por: Arévalo-Jaimes, Betsy Verónica, et al.
Publicado: (2019)

Efficacy of Clarithromycin Depends on the Bacterial Density in Clarithromycin-Heteroresistant Helicobacter pylori Infections: An In Situ Detected Susceptibility and Quantitative Morphometry-Based Retrospective Study
por: Kim, Jewel Ju Ea, et al.
Publicado: (2021)

A Vonoprazan, Clarithromycin, and Metronidazole Regimen as Helicobacter pylori Eradication Therapy for Patients with Penicillin Allergy in Light of Clarithromycin Resistance
por: Adachi, Kazunori, et al.
Publicado: (2023)

Efficacy of Clarithromycin Containing Bismuth–Based Regimen as a Second-Line Therapy in Helicobacter Pylori Eradication
por: Mokhtare, Marjan, et al.
Publicado: (2015)

Brief communication: global temporal trends in the efficacy of clarithromycin-based regimens for the treatment of Helicobacter pylori infection
por: Moss, Steven F., et al.
Publicado: (2023)

Variability in Prevalence of Helicobacter pylori Strains Resistant to Clarithromycin and Levofloxacin in Southern Poland
por: Karczewska, Elżbieta, et al.
Publicado: (2012)

Mutations in the 23S rRNA gene of Helicobacter pylori associated with clarithromycin resistance.
por: Kim, Kyung Suk, et al.
Publicado: (2002)

Impact of Helicobacter pylori Biofilm Formation on Clarithromycin Susceptibility and Generation of Resistance Mutations
por: Yonezawa, Hideo, et al.
Publicado: (2013)

Resistance pattern of Helicobacter pylori strains to clarithromycin, metronidazole, and amoxicillin in Isfahan, Iran
por: Khademi, Farzad, et al.
Publicado: (2013)

Detection of Helicobacter pylori resistance to clarithromycin and fluoroquinolones in Brazil: A national survey
por: Sanches, Bruno Squarcio, et al.
Publicado: (2016)

Antimicrobial susceptibility and clarithromycin resistance patterns of Helicobacter pylori clinical isolates in Vietnam
por: Quek, Camelia, et al.
Publicado: (2016)

Clarithromycin versus Gemifloxacin in Quadruple Therapeutic Regimens for Helicobacter Pylori Infection Eradication
por: Mansour-Ghanaei, Fariborz, et al.
Publicado: (2017)

Clarithromycin-Susceptible But Virulent Helicobacter pylori Strains Infecting Iranian Patients’ Stomachs
por: Khani, Shadiyeh, et al.
Publicado: (2019)

Primary and secondary clarithromycin resistance in Helicobacter pylori and mathematical modeling of the role of macrolides
por: Kocsmár, Éva, et al.
Publicado: (2021)

Benefits of a Molecular-Based Method for the Detection of Clarithromycin-Resistant Helicobacter pylori
por: Saruuljavkhlan, Batsaikhan, et al.
Publicado: (2021)

Helicobacter pylori Virulence Factors and Clarithromycin Resistance-Associated Mutations in Mexican Patients
por: Alarcón-Millán, Judit, et al.
Publicado: (2023)

Combating multidrug-resistant Helicobacter pylori with moenomycin A in combination with clarithromycin or metronidazole
por: Tseng, Yen-Yu, et al.
Publicado: (2022)

Real-Time Polymerase Chain Reaction for the Detection of Helicobacter pylori and Clarithromycin Resistance
por: Noh, Jin Hee, et al.
Publicado: (2023)

Helicobacter pylori in Dyspepsia: Phenotypic and Genotypic Methods of Diagnosis
por: Shetty, Vignesh, et al.
Publicado: (2017)

Clarithromycin vs. Gemifloxacin in Quadruple Therapy Regimens for Empiric Primary Treatment of Helicobacter pylori Infection: A Randomized Clinical Trial
por: Masoodi, Mohsen, et al.
Publicado: (2015)

Amoxicillin and Clarithromycin Mucoadhesive Delivery System for Helicobacter pylori Infection in a Mouse Model: Characterization, Pharmacokinetics, and Efficacy
por: Villegas, Isabel, et al.
Publicado: (2021)

Helicobacter pylori Primary and Secondary Genotypic Resistance to Clarithromycin and Levofloxacin Detection in Stools: A 4-Year Scenario in Southern Italy
por: Losurdo, Giuseppe, et al.
Publicado: (2020)

PNA-FISH as a new diagnostic method for the determination of clarithromycin resistance of Helicobacter pylori
por: Cerqueira, Laura, et al.
Publicado: (2011)

Comparison of Azithromycin and Clarithromycin Triple Therapy Regimens for Helicobacter Pylori Eradication in Hemodialysis Patients
por: Jalalzadeh, Mojgan, et al.
Publicado: (2012)

Low rate of recurrence of Helicobacter Pylori infection in spite of high clarithromycin resistance in Pakistan
por: Yakoob, Javed, et al.
Publicado: (2013)

RESISTANCE TO AMOXICILLIN, CLARITHROMYCIN AND CIPROFLOXACIN OF Helicobacter pylori ISOLATED FROM SOUTHERN BRAZIL PATIENTS
por: Picoli, Simone Ulrich, et al.
Publicado: (2014)

Eradication of Helicobacter pylori in Children by Triple Therapy Regimens of Amoxicillin, Omeprazole, and Clarithromycin or Azithromycin
por: Esmaeili-Dooki, Mohammad Reza, et al.
Publicado: (2015)

Low Dose Furazolidone for Eradication of Helicobacter pylori Instead of Clarithromycin: A Clinical Trial
por: Hajaghamohammadi, Aliakbar, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_kt9p1eadp2fjs8db9ul447artp